Pictet Asset Management (UK)’s Ascendis Pharma A/S ASND Stock Holding History

Pictet Asset Management (UK)’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-31,100	Closed	-$540K	–	855
2016 Q1	$540K	Hold	31,100	–	–	﹤0.01%	787
2015 Q4	$570K	Hold	31,100	–	–	﹤0.01%	810
2015 Q3	$551K	Hold	31,100	–	–	﹤0.01%	824
2015 Q2	$623K	Sell	31,100 -317,568	-91%	-$5.56M	﹤0.01%	827
2015 Q1	$5.94M	Buy	+348,668	New	+$6.34M	0.02%	554

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Pictet Asset Management (UK)'s ASND Position: Q2 2016 in Review

Pictet Asset Management (UK) sold out of Ascendis Pharma A/S (ASND) in Q2 2016, closing a stake of 31,100 shares — an estimated $540K sold.

Pictet Asset Management (UK) first reported a position in ASND in Q1 2015 and held it in 5 quarters. The position peaked at $5.94M in Q1 2015. 23 funds tracked by Wall St. Rank hold ASND as of Q2 2016.

Pictet Asset Management (UK) reported no remaining Ascendis Pharma A/S position as of Q2 2016 after selling out during the quarter.
Pictet Asset Management (UK) sold 31,100 Ascendis Pharma A/S shares in Q2 2016, an estimated $540K.
Pictet Asset Management (UK) first reported a position in Ascendis Pharma A/S in Q1 2015 and held it in 5 quarters.
Pictet Asset Management (UK)'s Ascendis Pharma A/S position peaked at $5.94M in Q1 2015.
23 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2016.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2016, filed 12 Aug 2016.